Atlas Trials

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

Clinical trial NCT00023335 · COMPLETED

Trial details

NCT number
NCT00023335
Sponsor
Centers for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary Tuberculosis
Start date
1995-04-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.